Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...
XDA Developers on MSN
I used NotebookLM to learn about advanced Python tricks in Excel and I should have sooner
Ever since Microsoft introduced Python in Excel, I have treated it as a ‘someday’ project. I knew Python integration was the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback